Virtus ETF Advisers’s Pfizer PFE Stock Holding History

Virtus ETF Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$734K	Sell	26,125 -1,986	-7%	-$52.9K	0.34%	65
2025 Q4	$700K	Buy	+28,111	New	+$709K	0.33%	73
2023 Q2	–	Sell	-19,730	Closed	-$805K	–	470
2023 Q1	$805K	Buy	19,730 +2,542	+15%	+$110K	0.44%	105
2022 Q4	$881K	Buy	17,188 +3,897	+29%	+$187K	0.46%	29
2022 Q3	$582K	Sell	13,291 -2,034	-13%	-$98.8K	0.23%	185
2022 Q2	$803K	Buy	+15,325	New	+$781K	0.3%	93
2020 Q3	–	Sell	-534	Closed	-$17K	–	408
2020 Q2	$17K	Sell	534 -131	-20%	-$4.45K	0.01%	392
2020 Q1	$21K	Sell	665 -16	-2%	-$545	0.01%	327
2019 Q4	$25K	Buy	681 +149	+28%	+$5.31K	﹤0.01%	336
2019 Q3	$18K	Hold	532	–	–	﹤0.01%	366
2019 Q2	$22K	Buy	+532	New	+$21.1K	﹤0.01%	357
2019 Q1	–	Sell	-532	Closed	-$22K	–	238
2018 Q4	$22K	Buy	+532	New	+$22.1K	﹤0.01%	221
2018 Q3	–	Sell	-1,076	Closed	-$37K	–	362
2018 Q2	$37K	Hold	1,076	–	–	0.03%	160
2018 Q1	$36K	Hold	1,076	–	–	0.03%	140
2017 Q4	$37K	Buy	+1,076	New	+$36.7K	0.05%	141

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Virtus ETF Advisers's PFE Position: Q1 2026 in Review

Virtus ETF Advisers reduced its Pfizer (PFE) stake by 7.1% in Q1 2026, selling an estimated $52.9K and leaving 26,125 shares worth $734K. The position accounts for 0.34% of the portfolio, ranked #65.

Virtus ETF Advisers first reported a position in PFE in Q4 2017 and has held it in 15 quarters since. The position peaked at $881K in Q4 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Virtus ETF Advisers held 26,125 shares of Pfizer worth $734K as of Q1 2026.
Virtus ETF Advisers sold 1,986 Pfizer shares in Q1 2026, an estimated $52.9K.
Pfizer made up 0.34% of Virtus ETF Advisers's portfolio in Q1 2026, its #65 holding.
Virtus ETF Advisers first reported a position in Pfizer in Q4 2017 and has held it in 15 quarters since.
Virtus ETF Advisers's Pfizer position peaked at $881K in Q4 2022.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Virtus ETF Advisers's 13F filing for Q1 2026, filed 14 May 2026.